RAET1E
From Wikipedia, the free encyclopedia
Retinoic acid early transcript 1E
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | RAET1E; LETAL; MGC125308; MGC125309; ULBP4; bA350J20.7 | |||||||||||||
External IDs | OMIM: 609243 HomoloGene: 51400 | |||||||||||||
|
||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 135250 | n/a | ||||||||||||
Ensembl | ENSG00000164520 | n/a | ||||||||||||
Uniprot | Q8TD07 | n/a | ||||||||||||
Refseq | NM_139165 (mRNA) NP_631904 (protein) |
n/a (mRNA) n/a (protein) |
||||||||||||
Location | Chr 6: 150.25 - 150.25 Mb | n/a | ||||||||||||
Pubmed search | [1] | n/a |
Retinoic acid early transcript 1E, also known as RAET1E, is a human gene.[1]
Members of the RAET1 family, such as RAET1E, are major histocompatibility complex (MHC) class I-related genes located within a 180-kb cluster on chromosome 6q24.2-q25.3. RAET1 proteins contain MHC class I-like alpha-1 and alpha-2 domains. RAET1E and RAET1G (MIM 609244) differ from the other RAET1 proteins (e.g., RAET1I, or ULBP1; MIM 605697) in that they have type I membrane-spanning sequences at their C termini rather than glycosylphosphatidylinositol anchor sequences. (Radosavljevic et al., 2002).[supplied by OMIM][1]
[edit] References
[edit] Further reading
- Radosavljevic M, Cuillerier B, Wilson MJ, et al. (2002). "A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3.". Genomics 79 (1): 114–23. doi: . PMID 11827464.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Chalupny NJ, Sutherland CL, Lawrence WA, et al. (2003). "ULBP4 is a novel ligand for human NKG2D.". Biochem. Biophys. Res. Commun. 305 (1): 129–35. PMID 12732206.
- Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.". Genome Res. 13 (10): 2265–70. doi: . PMID 12975309.
- Conejo-Garcia JR, Benencia F, Courreges MC, et al. (2004). "Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells.". Cancer Biol. Ther. 2 (4): 446–51. PMID 14508119.
- Mungall AJ, Palmer SA, Sims SK, et al. (2003). "The DNA sequence and analysis of human chromosome 6.". Nature 425 (6960): 805–11. doi: . PMID 14574404.
- Conejo-Garcia JR, Benencia F, Courreges MC, et al. (2004). "Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells.". Cancer Res. 64 (6): 2175–82. PMID 15026360.
- Bacon L, Eagle RA, Meyer M, et al. (2004). "Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D.". J. Immunol. 173 (2): 1078–84. PMID 15240696.
- Cao W, Xi X, Hao Z, et al. (2007). "RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity.". J. Biol. Chem. 282 (26): 18922–8. doi: . PMID 17470428.